AI
AUPH icon

Atom Investors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Atom Investors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,658
Closed -$154K – 484
2024
Q1 		$154K Buy
+30,658
New +$208K 0.02% 500
2020
Q3 		– Sell
-300,070
Closed -$4.88M – 507
2020
Q2 		$4.88M Sell
300,070
-141,233
-32% -$2.26M 0.32% 61
2020
Q1 		$6.4M Buy
441,303
+97,652
+28% +$1.72M 0.56% 43
2019
Q4 		$6.96M Buy
+343,651
New +$3.17M 0.57% 59

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Atom Investors's AUPH Position: Q2 2024 in Review

Atom Investors sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2024, closing a stake of 30,658 shares — an estimated $154K sold.

Atom Investors first reported a position in AUPH in Q4 2019 and held it in 4 quarters. The position peaked at $6.96M in Q4 2019. 171 funds tracked by Wall St. Rank hold AUPH as of Q2 2024.

  • Atom Investors reported no remaining Aurinia Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Atom Investors sold 30,658 Aurinia Pharmaceuticals shares in Q2 2024, an estimated $154K.
  • Atom Investors first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Atom Investors's Aurinia Pharmaceuticals position peaked at $6.96M in Q4 2019.
  • 171 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2024.

Based on Atom Investors's 13F filing for Q2 2024, filed 14 Aug 2024.